Safety and Tolerability of Triumeq in Amyotrophic Lateral Sclerosis: The Lighthouse Trial
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - United Kingdom
doi 10.1080/21678421.2019.1632899
Full Text
Open PDFAbstract
Available in full text
Date
July 8, 2019
Authors
Publisher
Informa UK Limited